Dermalogica, Inc.:企業の戦略・SWOT・財務情報

◆英語タイトル:Dermalogica, Inc. - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C1046
◆発行会社(調査会社):MarketLine
◆発行日:2018年7月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:消費財
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Dermalogica, Inc. – Strategy, SWOT and Corporate Finance Report
Summary

Dermalogica, Inc. – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Dermalogica, Inc. (Dermalogica), a subsidiary of Unilever N.V., is a beauty and personal care company. The company’s product portfolio comprises of moisturizers, toners, masques, concentrated boosters, skin kits, shaving products, cleansers, exfoliants and conditioners, among others. Majorly offers products for treatment of specific skin conditions. Dermalogica markets its products through proprietary concept spaces, online store and professional skin therapists worldwide. It operates concept spaces in the US, Bahamas, the UK, Germany, India, Australia and the UAE. The company also operates International Dermal Institute to train skin care therapists. Dermalogica is headquartered in Carson, California, the US.

Scope

- Detailed information on Dermalogica, Inc. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Dermalogica, Inc. in the form of a SWOT analysis
- An in-depth view of the business model of Dermalogica, Inc. including a breakdown and examination of key business segments
- Intelligence on Dermalogica, Inc.’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Dermalogica, Inc., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Dermalogica, Inc. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Dermalogica, Inc. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Dermalogica, Inc.’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 4
Dermalogica, Inc.: Company Overview 7
Dermalogica, Inc.: Overview and Key Facts 7
Dermalogica, Inc.: Overview 7
Dermalogica, Inc.: Key Facts 7
Dermalogica, Inc.: Key Employees 8
Dermalogica, Inc.: Major Products and Services 9
Dermalogica, Inc.: Company History 10
Dermalogica, Inc.: Locations and Subsidiaries 12
Dermalogica, Inc.: Key Competitors 13
Dermalogica, Inc.: Company Analysis 14
Dermalogica, Inc.: Business Description 14
Dermalogica, Inc.: SWOT Analysis 16
Dermalogica, Inc.: SWOT Overview 16
Dermalogica, Inc.: Strengths 16
Dermalogica, Inc.: Weaknesses 17
Dermalogica, Inc.: Opportunities 17
Dermalogica, Inc.: Threats 17
Dermalogica, Inc.: Corporate Financial Deals Activity 19
Dermalogica, Inc.: Financial Deals Overview 19
Dermalogica, Inc.: Top Deals 2014 – 2018YTD* 20
Dermalogica, Inc.: Advisors 21
Dermalogica, Inc.: Top Legal Advisors 21
Dermalogica, Inc.: Private Equity and Ownership 22
Appendix 23
Contact Us 23
Methodology 23
About MarketLine 24

List of Tables
Table 1: Dermalogica, Inc.: Key Facts
Table 2: Dermalogica, Inc.: Key Employees
Table 3: Dermalogica, Inc.: Locations and Subsidiaries
Table 4: Dermalogica, Inc.: Key Competitors
Table 5: Dermalogica, Inc.: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 6: Dermalogica, Inc.: Top Deals 2014 - 2018YTD*
Table 7: Dermalogica, Inc.: Legal Advisor Ranking by Value (US$m)
Table 8: Dermalogica, Inc.: Private Equity and Ownership Volume and Value Trend (2014 - YTD*2018)
Table 9: Dermalogica, Inc.: Private Equity and Ownership Volume by Deal Type (2014 - YTD*2018)

List of Figures
Figure 1: Dermalogica, Inc.: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 2: Dermalogica, Inc.: Private Equity and Ownership Volume and Value Trend (2014 - YTD*2018)
Figure 3: Dermalogica, Inc.: Private Equity and Ownership Volume by Deal Type (2014 - YTD*2018)

★海外企業調査レポート[Dermalogica, Inc.:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Pantheon Resources plc Oil & Gas Exploration and Production Operations and Cost Analysis – 2017
    Pantheon Resources plc Oil & Gas Exploration and Production Operations and Cost Analysis - 2017 Summary Pantheon Resources plc Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive informat …
  • NOW Inc (DNOW):企業の財務・戦略的SWOT分析
    NOW Inc (DNOW) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • Active Biotech AB (ACTI):製薬・医療:M&Aディール及び事業提携情報
    Summary Active Biotech AB (Active Biotech) is a biotechnology company that develops and commercializes pharmaceuticals in the field of inflammatory/neurodegenerative diseases and cancer. The company’s key products in development include Laquinimod (neurodegenerative diseases); Anyara (cancer); Tasqu …
  • Dr. Reddy’s Laboratories Ltd (DRREDDY):製薬・医療:M&Aディール及び事業提携情報
    Summary Dr. Reddy's Laboratories Ltd (Dr. Reddy's) is a pharmaceutical company which manufactures and markets generic formulations, active pharmaceutical ingredients, biosimilars and proprietary products. The company’s generic products are used for the treatment of conditions such as gastrointestina …
  • Agfa-Gevaert N.V.:企業の戦略・SWOT・財務情報
    Agfa-Gevaert N.V. - Strategy, SWOT and Corporate Finance Report Summary Agfa-Gevaert N.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Apollo Commercial Real Estate Finance, Inc.:企業のM&A・事業提携・投資動向
    Apollo Commercial Real Estate Finance, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Apollo Commercial Real Estate Finance, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, det …
  • Elektrani na Makedonija:企業の戦略的SWOT分析
    Elektrani na Makedonija - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Carisma Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Carisma Therapeutics Inc (Carisma Therapeutics), formerly CARMA Therapeutics LLC, is a biotechnology company with focus on the discovery and development of macrophage-based immunotherapeutics for the treatment of cancer. The company exploits its proprietary CAR-macrophage platform to provide …
  • Qatar Islamic Bank:企業の戦略・SWOT・財務分析
    Qatar Islamic Bank - Strategy, SWOT and Corporate Finance Report Summary Qatar Islamic Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • MKB Private Banking:企業の戦略・SWOT・財務情報
    MKB Private Banking - Strategy, SWOT and Corporate Finance Report Summary MKB Private Banking - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • FTS International Services LLC:企業の戦略的SWOT分析
    FTS International Services LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • Sempra U.S. Gas & Power LLC-エネルギー分野:企業M&A・提携分析
    Summary Sempra U.S. Gas & Power, LLC (Sempra US), a subsidiary of Sempra Energy, an energy solution provider, is a clean power solutions developer. It develops, designs, constructs and operates renewable energy and natural gas solutions, with a focus on zero and low emission fuels. The company owns …
  • Pernix Therapeutics Holdings Inc (PTX):製薬・医療:M&Aディール及び事業提携情報
    Summary Pernix Therapeutics Holdings Inc (Pernix Therapeutics) is a specialty pharmaceutical company that discovers, develops, and markets generic pharmaceutical products. The company’s portfolio encompasses a fixed dose combination product prescribed to treat acute migraine; an extended-release (XR …
  • Crown Castle International Corp (CCI):企業の財務・戦略的SWOT分析
    Crown Castle International Corp (CCI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • The Allstate Corp:企業の戦略・SWOT・財務情報
    The Allstate Corp - Strategy, SWOT and Corporate Finance Report Summary The Allstate Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • USV Pvt Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary USV Pvt Ltd (USV) is a healthcare company that offers pharmaceutical products. The company’s products include active pharmaceutical ingredients, biosimilars, injectables, ophthalmics, peptides and solid orals. Its biosimilars products comprise PEG-filgrastim, teriparatide, somatropin, filgra …
  • Medical Prognosis Institute AS (MPI):医療機器:M&Aディール及び事業提携情報
    Summary Medical Prognosis Institute A/S (MPI) is a precision medicine provider that offers cancer treatment solutions. The company offers drug response prediction platforms that provide tools for rationalized drug development and personalized medicine. It offers lead compound selection, drug rescue …
  • GEO Specialty Chemicals Inc:企業の戦略的SWOT分析
    GEO Specialty Chemicals Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • NuVasive Inc (NUVA):製品パイプライン分析
    Summary NuVasive Inc (NuVasive) is a medical device company that provides minimally invasive, procedurally-integrated spine solutions. The company principally provides Maximum Access Surgery (MAS), a minimally-disruptive surgical platform. MAS platform enables surgeons to perform a range of minimall …
  • Peace River Electric Cooperative, Inc.:企業の発電所・SWOT分析2018
    Peace River Electric Cooperative, Inc. - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, informati …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆